Main Article Content
Objective: Currently, mononuclear cell (MNC) isolation is performed using density gradient methods, which are laborious and time-consuming, requiring a minimum of 10 ml of buffy coat or blood. This method is inadequate for isolating MNCs from small volumes, such as 100 µl. Therefore, we aimed to develop a straightforward, rapid, and cost-effective method for isolating MNCs from minute volumes of blood and buffy coat.
Material and Methods: We utilized the MNC isolator to isolate MNCs from microvolumes, such as 100 µl and 500 µl of blood and buffy coat, by simple mixing and centrifugation. The isolated cells were cultured, and ligand-specific magnetic beads were employed to isolate CD4 and CD45 specific cells from the cultured cells.
Results: In 15 experiments, the MNC isolator successfully isolated MNCs from small volumes of blood and buffy coat. The cell cultures were established and maintained for up to 3 years without contamination, with the cells remaining healthy. Successful isolations of CD4 and CD45 cells using magnetic beads were achieved, and the cells were successfully frozen and thawed.
Conclusion: In this study, we have introduced a simple, cost-effective, and robust method for isolating MNCs from small volumes of buffy coat and blood, suitable for immunological applications and magnetic bead cell isolation. This method is user-friendly and can be adopted in cell culture laboratories worldwide, potentially opening new avenues for the development of novel antibodies, isolation of various cell populations using magnetic beads, and obtaining a large number of T-cells for immunotherapy development, such as CAR T-cell therapies.
Keywords: mononuclear cell isolation, buffy coat, blood, CD4 positive cells, magnetic beads
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Boyum A. Separation of white blood cells. Nature. 1964;204:793-4. DOI: https://doi.org/10.1038/204793a0
Boyum A. Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Suppl. 1968;97:9-29.
Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Euro Heart J. 2007;28 (6):766–772. DOI: https://doi.org/10.1093/eurheartj/ehl509
Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109(13):1615-22. DOI: https://doi.org/10.1161/01.CIR.0000124476.32871.E3
Hombach A, Hombach AA, Abken H. Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc 'spacer' domain in the extracellular moiety of chimeric antigen receptors avoids 'off-target' activation and unintended initiation of an innate immune response. Gene Ther. 2010;17(10):1206-13. DOI: https://doi.org/10.1038/gt.2010.91
Levine BL, Miskin J, Wonnacott K, Keir C. Global Manufacturing of CAR T Cell Therapy. Mol Ther Methods Clin Dev. 2016;4:92-101. DOI: https://doi.org/10.1016/j.omtm.2016.12.006
Fibriansah G, Lok SM. The development of therapeutic antibodies against dengue virus. Antiviral Res. 2016;128:7-19. DOI: https://doi.org/10.1016/j.antiviral.2016.01.002
Wolf C, Köppert S, Becza N, Kuerten S, Kirchenbaum GA, Lehmann PV. Antibody Levels Poorly Reflect on the Frequency of Memory B Cells Generated following SARS-CoV-2, Seasonal Influenza, or EBV Infection. Cells. 2022;11(22):3662. DOI: https://doi.org/10.3390/cells11223662
Mallone R, Mannering SI, Brooks-Worrell BM, Durinovic-Belló I, Cilio CM, Wong FS et al. Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society. Clin Exp Immunol. 2011;163(1):33–49. DOI: https://doi.org/10.1111/j.1365-2249.2010.04272.x
Strelkauskas AJ, Teodorescu M, Dray S. Enumeration and isolation of human T and B lymphocytes by rosette formation with antibody-coated erythrocytes. Clin Exp Immunol. 1975;22(1):62-71.
Ulmer AJ, Scholz W, Ernst M, Brandt E, Flad HD. Isolation and Subfractionation of Human Peripheral Blood Mononuclear Cells (PBMC) by Density Gradient Centrifugation on Percoll. Immunobiol. 1984;166(3):238-250. DOI: https://doi.org/10.1016/S0171-2985(84)80042-X
Nilsson C, Aboud S, Karlén K, Hejdeman B, Urassa W, Biberfeld G. Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects. Clin Vaccine Immunol. 2008;15(4):585-9. DOI: https://doi.org/10.1128/CVI.00161-07
Ramachandran H, Laux J, Moldovan I, Caspell R, Lehmann PV, Subbramanian RA. Optimal thawing of cryopreserved peripheral blood mononuclear cells for use in high-throughput human immune monitoring studies. Cells. 2012;1(3):313-24. DOI: https://doi.org/10.3390/cells1030313
Khan MWA, Otaibi AA, Sherwani S, Alshammari EM, Al-Zahrani SA, Khan WA et al. Optimization of methods for peripheral blood mononuclear cells isolation and expansion of human gamma delta T cells. Bioinformation. 2021;17(3):460-469. DOI: https://doi.org/10.6026//97320630017460
Patrone D, Alessio N, Antonucci N, Brigida AL, Peluso G, Galderisi U et al. Optimization of Peripheral Blood Mononuclear Cell Extraction from Small Volume of Blood Samples: Potential Implications for Children-Related Diseases. Methods Protoc. 2022;5(2):20. DOI: https://doi.org/10.3390/mps5020020
Hamot G, Ammerlaan W, Mathay C, Kofanova O, Betsou F. Method validation for automated isolation of viable peripheral blood mononuclear cells. Biopreserv Biobank. 2015;(3):152-63. DOI: https://doi.org/10.1089/bio.2014.0054
Fuchs YF, Brunner J, Weigelt M, Schieferdecker A, Morgenstern R, Sturm A et al. Next Generation Biobanking: Employing a Robotic System for Automated Mononuclear Cell Isolation. Biopreserv Biobank. 2023;21(1):106-110. DOI: https://doi.org/10.1089/bio.2021.0181
Bhatia S. 2-3% fetal calf serum in cell media is sufficient for the development and growth of human mononuclear cell cultures. Atlantic J Med Sci Res. 2023;3(2):46-9. DOI: https://doi.org/10.5455/atjmed.2023.01.06